Whitney S. Goldner

TL;DR: These guidelines focus on sporadic NETs of the pancreas, gastrointestinal tract, lung, and thymus, which are associated with symptoms attributable to hormonal hypersecretion.

TL;DR: These NCCN Guidelines Insights summarize the management options and the 2018 updates to the guidelines for locoregional advanced disease, and/or distant metastasis originating from gastrointestinal tract, bronchopulmonary, and thymus primary NETs.

TL;DR: The panel discussion behind recent updates to the NCCN Guidelines Insights summarized the expanding role of molecular testing for differentiated thyroid carcinoma, implications of the new pathologic diagnosis of noninvasive follicular thyroid neoplasm with papillary-like nuclear features, and the addition of a new targeted therapy option for BRAF V600E-mutated anaplastic thyroid carcinomas.

TL;DR: The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Neuroendocrine and Adrenal Gland Tumors focus on the diagnosis, treatment, and management of patients with neuroendocrine tumors (NETs), adrenal tumors, pheochromocytomas, paragangliomas, and multiple endocrine neoplasia as mentioned in this paper.

TL;DR: Increased vitamin D deficiency in obese persons cannot be explained by a difference in calcium/vitamin D intake or sunlight exposure, and these findings suggest that vitamin D deficiencies after bariatric surgery is multifactorial and in part caused by preoperativeitamin D deficiency rather than postoperative mal absorption alone.